Medicare GLP-1 Coverage and Pricing: How to Calculate Your Out-of-Pocket Costs

Medicare is expanding GLP-1 weight-loss drug coverage, which means millions of eligible beneficiaries may soon access medications like Wegovy and Zepbound at significantly reduced prices. Understanding exactly what you'll pay requires knowing your plan type, coverage phase, and income level — and running the actual numbers through a reliable cost calculator.

What the New Medicare GLP-1 Coverage Actually Means

For years, Medicare Part D explicitly excluded weight-loss drugs from coverage. That policy has been shifting. The landmark change came when the FDA approved semaglutide (Wegovy) for cardiovascular risk reduction — not just obesity — which opened the door for Medicare to cover it under existing rules. Now, broader coverage for GLP-1 medications used specifically for obesity management is on the horizon, with proposed rules from the Centers for Medicare and Medicaid Services signaling a major policy shift.

This isn't a done deal across every plan, and timing matters. Some Medicare Advantage and Part D plans have already begun covering certain GLP-1 drugs. Others are waiting on final federal guidance. What's consistent is that the conversation has fundamentally changed — and if you're a Medicare beneficiary managing your weight or cardiovascular risk, there are real dollars at stake right now.

Which GLP-1 Drugs Are Being Covered?

The medications generating the most coverage discussion include semaglutide (brand names Ozempic and Wegovy), tirzepatide (Mounjaro and Zepbound), and liraglutide (Saxenda). Coverage eligibility often depends on the specific indication listed by your prescriber. A diabetes diagnosis has historically made GLP-1 coverage much more accessible under Part D, while an obesity-only diagnosis faced more barriers — barriers that are actively being dismantled.

How CMS Is Driving the Change

According to CMS.gov, the agency has proposed rules that would require Medicare Part D plans to cover anti-obesity medications, which would represent a historic expansion of benefits. If finalized, this rule could extend affordable GLP-1 access to an estimated 3.4 million Medicare beneficiaries annually, according to CMS projections.

Understanding Medicare's Cost Structure for Prescription Drugs

Before you can calculate what you'll actually pay for a GLP-1 drug under Medicare, you need to understand how Part D pricing works. It's not a flat copay system — it's a phased structure that changes based on how much you've spent in a given year.

The 2025 Medicare Part D Coverage Phases

Medicare Part D operates in distinct spending phases that directly affect your out-of-pocket cost for expensive drugs like GLP-1s:

• Deductible Phase: In 2025, the standard Part D deductible is $590. You pay 100% of drug costs until you hit this amount.
• Initial Coverage Phase: After your deductible, you pay 25% of drug costs while your plan pays 75%, up to a defined threshold.
• Catastrophic Coverage Phase: A major change in 2025 — once you hit $2,000 in out-of-pocket drug spending, your cost-sharing drops to $0 for the rest of the year. This is new for 2025 and is a significant benefit for people on high-cost medications like GLP-1s.

This structure matters enormously for GLP-1 users because these drugs carry list prices ranging from $900 to over $1,300 per month before any coverage. Without insurance, the annual cost can exceed $15,000. With Medicare Part D and the new $2,000 out-of-pocket cap, your maximum annual exposure is dramatically lower.

Medicare Advantage vs. Stand-Alone Part D Plans

If you receive Medicare through a Medicare Advantage (Part C) plan, your drug coverage is bundled into your plan's benefits rather than through stand-alone Part D. Advantage plans have more flexibility in how they structure drug tiers and prior authorization requirements. This means GLP-1 coverage rules, copays, and step therapy requirements can vary significantly between plans — another reason why running your specific numbers through a GLP-1 cost calculator is more useful than relying on general estimates.

How to Calculate Your GLP-1 Out-of-Pocket Costs Under Medicare

Estimating what you'll actually pay involves several variables working together. Here's the methodology to follow:

Step 1: Identify Your Drug and Its Formulary Tier

Every Part D plan places drugs into tiers, typically ranging from Tier 1 (lowest cost generics) to Tier 5 (specialty drugs). GLP-1 medications are almost always placed at Tier 4 or Tier 5, which carries the highest cost-sharing percentages. Your plan's Summary of Benefits or the Medicare Plan Finder tool at medicare.gov will show you exactly which tier your drug falls under.

Step 2: Apply the Coverage Phase Math

Once you know your drug's negotiated price under your plan, you can model your spending through each phase. For example, if Wegovy has a negotiated price of $850/month under your plan:

• You'd clear the $590 deductible partway through your first fill
• You'd pay 25% of costs during the initial coverage phase
• You'd hit the $2,000 out-of-pocket cap relatively quickly — potentially within the first 2-3 months
• After that cap, you pay $0 for the remainder of the year

This is why the 2025 cap change is so significant for GLP-1 users specifically. High monthly drug costs that once created year-long financial burden now have a ceiling.

Step 3: Factor In Low-Income Subsidy (LIS/Extra Help)

If your income and resources fall below certain thresholds, you may qualify for Medicare's Extra Help program (also called the Low-Income Subsidy). According to CMS, Extra Help can reduce or eliminate Part D premiums, deductibles, and copays — including for specialty drugs. For a GLP-1 user, Extra Help could mean paying as little as a few dollars per fill instead of hundreds. You can check eligibility through SSA.gov or your State Health Insurance Assistance Program (SHIP).

Use our GLP-1 cost calculator to model how different subsidy levels affect your total annual spending.

Factors That Can Raise or Lower What You Pay

Your final out-of-pocket cost isn't determined by coverage phase alone. Several additional factors push costs up or down in meaningful ways.

Prior Authorization and Step Therapy Requirements

Most Part D plans require prior authorization before covering a GLP-1 drug, meaning your doctor must submit documentation showing medical necessity. Some plans also require step therapy — you may need to try and fail on a cheaper medication before the plan approves the GLP-1. Both processes take time and can create gaps in coverage if not navigated correctly. Working closely with your prescriber on documentation is essential.

Plan Premium Differences

Plans that include GLP-1 coverage may charge higher monthly premiums to offset the cost of covering these expensive medications. When evaluating total cost, factor in both your drug cost-sharing and your monthly premium. A plan with a higher premium but better GLP-1 coverage could still save you money overall depending on your usage pattern.

Manufacturer Savings Programs

Some GLP-1 manufacturers offer savings programs, though eligibility for Medicare beneficiaries is typically limited due to federal anti-kickback rules. These programs are generally more accessible to commercially insured patients. However, it's worth checking directly with manufacturers like Novo Nordisk (Wegovy) and Eli Lilly (Zepbound) to understand what's available to Medicare patients specifically.

When Will Broader GLP-1 Coverage Take Effect?

Timing for expanded Medicare GLP-1 coverage depends on the regulatory process. CMS proposed rules would need to be finalized before taking effect. Industry watchers have estimated potential implementation in plan year 2026, though political and budgetary factors influence the timeline. The Congressional Budget Office estimated that expanding Medicare coverage of anti-obesity drugs could cost the federal government approximately $35 billion over a decade — a figure that's central to ongoing policy debates.

In the meantime, some coverage already exists for beneficiaries with qualifying diagnoses. Don't assume you have to wait — check your current plan's formulary today.

Frequently Asked Questions About Medicare GLP-1 Costs

Does Medicare currently cover Wegovy or Zepbound for weight loss?

Coverage depends on your specific plan and diagnosis. Medicare Part D plans can currently cover Wegovy for cardiovascular risk reduction under certain conditions. Coverage for obesity alone is more limited but is expanding. Zepbound coverage under Medicare varies by plan. Check your plan's formulary directly or use the Medicare Plan Finder tool to see your specific coverage details.

What is the maximum I would pay out of pocket for a GLP-1 drug under Medicare in 2025?

In 2025, Medicare Part D introduced a $2,000 annual out-of-pocket cap on drug costs. This means that regardless of how expensive your GLP-1 medication is, your maximum personal spending on covered drugs under Part D is capped at $2,000 per year. This is one of the most significant changes for beneficiaries taking high-cost specialty medications.

How do I know if I qualify for Extra Help to reduce my GLP-1 costs?

Extra Help (Low-Income Subsidy) eligibility is based on income and resources. Generally, individuals with annual income below roughly 150% of the federal poverty level may qualify. You apply through the Social Security Administration. If approved, your cost-sharing for GLP-1 drugs could be reduced to just a few dollars per prescription. Your local SHIP counselor can help you apply for free.

Can I use a GLP-1 cost calculator to compare Medicare plan options?

Yes — and this is one of the most practical uses of a cost calculator. By entering your specific drug, dosage, and plan details into a GLP-1 cost calculator, you can compare estimated annual spending across different plans during Medicare Open Enrollment (October 15 – December 7 each year). This comparison can reveal hundreds or even thousands of dollars in potential savings.